• 1
    Castano L & Eisenbarth GS. Type-I Diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 1990; 8:64779.
  • 2
    Kikutani H & Smakino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992; 51:285323.
  • 3
    Toyoda H & Formby B. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model. Bioessays 1998; 20:7507.DOI: 10.1002/(sici)1521-1878(199809)20:9<750::aid-bies8>;2-k
  • 4
    Todd JA. From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays 1999; 21:16174.
  • 5
    Mosmann TR & Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:14573.
  • 6
    Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16:348.
  • 7
    Charlton B & Lafferty KJ. The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 1995; 7:7938.
  • 8
    Goldman M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12:2237.
  • 9
    Griem P & Gleichmann E. Metal ion induced autoimmunity. Curr Opin Immunol 1995; 7:8318.
  • 10
    Eneström S & Hultman P. Does amalgam affect the immune system? A controversial issue. Int Arch Allergy Immunol 1995; 106:180203.
  • 11
    Goter Robinson CJ, Abraham AA, Balazs T. Induction of anti-nuclear antibodies by mercuric chloride in mice. Clin Exp Immunol 1984; 58:3006.
  • 12
    Hultman P & Eneström S. Mercury induced B-cell activation and antinuclear antibodies in mice. Clin Lab Immunol 1989; 28:14350.
  • 13
    Hultman P & Eneström S. Murine mercury-induced immune-complex disease: effect of cyclophosphamide treatment and importance of T cells. Br J Exp Path 1989; 70:22736.
  • 14
    Hultman P, Johansson U, Dagnaes-Hansen F. Murine mercury-induced autoimmunity: the role of T-helper cells. J Autoimmun 1995; 8:80923.
  • 15
    Mirtcheva J, Pfeiffer C, De Bruijn JA et al. Immunological alterations inducible by mercury compounds. III. H-2A acts as an immune response and H-2E as an immune ‘suppression’ locus for HgCl2-induced antinucleolar autoantibodies. Eur J Immunol 1989; 19:225761.
  • 16
    Hultman P, Bell LJ, Eneström S et al. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic and intra-H-2 recombinant strains. Clin Immunol Immunopathol 1992; 65:98109.
  • 17
    Hultman P, Bell LJ, Eneström S et al. Murine susceptibility to mercury. II. Autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. Clin Immunol Immunopathol 1993; 68:920.DOI: 10.1006/clin.1993.1088
  • 18
    Hultman P, Turley SJ, Eneström S et al. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J Autoimmun 1996; 9:13949.DOI: 10.1006/jaut.1996.0017
  • 19
    Hanley GA, Schiffenbauer J, Sobel ES. Class II haplotype differentially regulates immune response in HgCl2-treated mice. Clin Immunol Immunopathol 1997; 84:32837.DOI: 10.1006/clin.1997.4405
  • 20
    Abedi-Valugerdi M & Möller G. Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. Int Immunol 2000; 12:142530.DOI: 10.1093/intimm/12.10.1425
  • 21
    Mathieson PW. Mercury: god of Th2 cells. Clin Exp Immunol 1995; 102:22930.
  • 22
    Gronowicz E, Coutinho A, Melchers F. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol 1976; 6:58890.
  • 23
    Al-Balaghi S, Möller E, Möller G et al. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB × NZW) F1 hybrids. Eur J Immunol 1996; 26:151926.
  • 24
    Heid CA, Stevens J, Livak KJ et al. Real time quantitative PCR. Genome Res 1996; 6:98694.
  • 25
    Hu H, Möller G, Abedi-Valugerdi G. Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunol 1999; 96:34857.
  • 26
    Snapper CM, Finkelman FD, Paul WE. Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev 1988; 102:5177.
  • 27
    Finkelman FD, Holmes J, Katona IM et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8:30335.
  • 28
    Ochel M, Vohr H-W, Pfeiffer C et al. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 1991; 146:300611.
  • 29
    Hattori M, Buse JB, Jackson RA et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 1986; 231:7335.
  • 30
    Acha-Orbea H & McDevitt HO. The first external domain of the nonobese diabetic mouse class II, I–A b chain is unique. Proc Natl Acad Sci 1987; 84:24352439.
  • 31
    Hultman P & Eneström S. Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits. Clin Exp Immunol 1988; 71:26974.
  • 32
    Abedi-Valugerdi M, Hu H, Möller G. Mercury-induced renal immune complex deposits in young (NZB × NZW) F1 mice: characterization of antibodies/autoantibodies. Clin Exp Immunol 1997; 110:8691.
  • 33
    Gillespie KM, Saoudi A, Kuhn J et al. Th1/Th2 cytokine gene expression after mercury chloride in susceptible and resistant rat strains. Eur J Immunol 1996; 26:238892.
  • 34
    Kono DH, Balomenos D, Pearson DI et al. The prototype Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th/Th2 imbalance. J Immunol 1998; 161:23440.
  • 35
    Martin RM, Brady JL, Lew AM. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Meth 1998; 212:18792.
  • 36
    Pelletier L, Galceran M, Pasquier R et al. Down regulation of Hemann's nephritis by mercuric chloride. Kidney Int 1987; 32: 22732.
  • 37
    Pelletier L, Rossert J, Pasquier R et al. Effect of HgCl2 on experimental allergic encephalomyelitis in Lewis rats. HCl2-induced down-regulation of the disease. Eur J Immunol 1988; 18:2437.
  • 38
    Saoudi A, Bellon B, De Kozak Y et al. Prevention of experimental autoimmune uveoretinitis and experimental autoimmune pinealitis in (Lewis × Brown-Norway) F1 rats by HgCl2 injections. Immunol 1991; 74:34854.
  • 39
    Stosic-Grujicic S, Mijatovic S, Ejdus L et al. Enhancement of Th2-type activity downregulated diabetes induction. Transplant Proc 1996; 28:3257.
  • 40
    Bridoux F, Badou A, Saoudi A et al. Transforming growth factor β (TGF-β)-dependent inhibition of T Helper cell 2 (Th2) -induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4+ T cell lines. J Exp Med 1997; 185: 176975.
  • 41
    Saoudi A, Kuhn J, Huygen K et al. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 1993; 23:3096103.
  • 42
    Cameron MJ, Arreaza GA, Zucker P et al. 1997. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in non-obese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 1997; 159:468692.
  • 43
    Jaramillo A, Gill BM, Deloyitch TL. Insulin dependent diabete mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy? Life Sci 1994; 55:116377.
  • 44
    Rapoport MJ, Jaramillo A, Zipris D et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178:8799.
  • 45
    Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 1996; 184:10939.